X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (372) 372
life sciences & biomedicine (370) 370
humans (368) 368
cardiovascular system & cardiology (324) 324
cardiac & cardiovascular systems (317) 317
male (236) 236
female (215) 215
atrial fibrillation (205) 205
middle aged (175) 175
aged (172) 172
abridged index medicus (143) 143
risk factors (106) 106
treatment outcome (102) 102
atrial fibrillation - drug therapy (96) 96
electrocardiography (90) 90
cardiac arrhythmia (79) 79
stroke (78) 78
prospective studies (72) 72
follow-up studies (67) 67
cardiology (66) 66
anti-arrhythmia agents - therapeutic use (63) 63
defibrillators, implantable (61) 61
cardiovascular (60) 60
atrial fibrillation - complications (53) 53
adult (52) 52
drug therapy (52) 52
medical and health sciences (52) 52
medicin och hälsovetenskap (52) 52
aged, 80 and over (50) 50
anticoagulants (48) 48
care and treatment (48) 48
mortality (48) 48
stroke - prevention & control (48) 48
kardiologi (44) 44
atrial fibrillation - physiopathology (43) 43
peripheral vascular disease (43) 43
warfarin (43) 43
cardiology and cardiovascular medicine (42) 42
atrial fibrillation - therapy (41) 41
heart failure (41) 41
anticoagulants - therapeutic use (40) 40
cardiac and cardiovascular systems (40) 40
time factors (40) 40
clinical medicine (39) 39
risk assessment (39) 39
atrial fibrillation - diagnosis (37) 37
general & internal medicine (37) 37
prognosis (37) 37
medicine, general & internal (36) 36
atrial fibrillation - mortality (35) 35
catheter ablation (35) 35
klinisk medicin (35) 35
amiodarone - therapeutic use (34) 34
anticoagulation (33) 33
arrhythmia (33) 33
heart attacks (32) 32
anti-arrhythmia agents - adverse effects (31) 31
double-blind method (31) 31
tachycardia, ventricular - physiopathology (31) 31
incidence (30) 30
sudden cardiac death (30) 30
implants, artificial (29) 29
myocardial infarction - complications (29) 29
prosthesis (29) 29
clinical trials (28) 28
death, sudden, cardiac - prevention & control (28) 28
cardiac patients (27) 27
fibrillation (27) 27
heart rate (27) 27
hemorrhage - chemically induced (27) 27
stroke - etiology (27) 27
prevention (26) 26
amiodarone - analogs & derivatives (25) 25
anticoagulants - adverse effects (25) 25
cardioversion (25) 25
dabigatran (25) 25
myocardial infarction (25) 25
predictive value of tests (25) 25
warfarin - therapeutic use (25) 25
kaplan-meier estimate (24) 24
medicine & public health (24) 24
randomized controlled trials as topic (24) 24
tachycardia, ventricular - therapy (24) 24
amiodarone - adverse effects (23) 23
anticoagulants - administration & dosage (23) 23
internal medicine (23) 23
pacemaker, artificial (23) 23
anti-arrhythmia drugs (22) 22
cardiovascular disease (22) 22
electric countershock (22) 22
electrophysiology (22) 22
heart (22) 22
medical research (22) 22
tachycardia (22) 22
ventricular tachycardia (22) 22
animals (21) 21
bleeding (21) 21
analysis (20) 20
arrhythmias, cardiac - physiopathology (20) 20
defibrillators (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
European heart journal, ISSN 1522-9645, 05/2014, Volume 35, Issue 25, pp. 1642 - 1651
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2011, Volume 365, Issue 11, pp. 981 - 992
Journal Article